Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | PLAT | P00750 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.48 |
| ▸ | GABRE | P78334 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.48 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.48 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL135660 | 1.00 | LMNA (0.48) | LMNAPLGPLATTSHRGABRP | |
| SCHEMBL265529 | 1.00 | LMNA (0.48) | LMNAPLGPLATTSHRGABRP | |
| Hydrochloric Acid SCHEMBL134213 | 0.97 | LMNA (0.46) | LMNAPLGPLATTSHRGABRP | |
| SCHEMBL9820825 | 0.97 | TSHR (0.52) | LMNAPLGPLATTSHRGABRP | |
| SCHEMBL6913949 | 0.97 | LMNA (0.46) | LMNAPLGPLATTSHRGABRP | |
| SCHEMBL6914968 | 0.97 | LMNA (0.46) | LMNAPLGPLATTSHRGABRP | |
| SCHEMBL6908741 | 0.97 | LMNA (0.46) | LMNAPLGPLATTSHRGABRP | |
| SCHEMBL6916906 | 0.97 | LMNA (0.46) | LMNAPLGPLATTSHRGABRP | |
| SCHEMBL6917784 | 0.97 | LMNA (0.46) | LMNAPLGPLATTSHRGABRP | |
| Hydrochloric Acid SCHEMBL10723734 | 0.97 | LMNA (0.46) | LMNAPLGPLATTSHRGABRP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1738 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025233946-A1 | COMBINATIONS OF PLASMINOGEN ACTIVATOR MUTANTS AND LYSINE ANALOGS FOR INHIBITING COAGULATION AND ASSOCIATED CONDITIONS | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) | 2025-11-13 | — | — | WO | claimed |
| CN-120138636-A | Corrosion inhibitor for cooling liquid, cooling liquid and preparation method thereof | 深圳市英维克科技股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-11976138-B2 | Thermally stable cellulose ester compositions and articles made using these compositions | EASTMAN CHEMICAL COMPANY (US) | 2024-05-07 | — | — | US | claimed |
| CN-111770767-B | Extracorporeal device and matrix for removing plasmin from biological fluids, method and use thereof | 普拉斯富瑞有限公司 | 2024-03-05 | — | — | CN | claimed |
| EP-3688124-B1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-25 | — | — | EP | claimed |
| US-20220213090-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | INCYTE CORPORATION | 2022-07-07 | — | — | US | claimed |
| US-20220194931-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | INCYTE CORPORATION | 2022-06-23 | — | — | US | claimed |
| US-11208562-B2 | Zirconium oxide nanoparticles | NIPPON SHOKUBAI CO., LTD. (JP) | 2021-12-28 | — | — | US | claimed |
| US-20210001023-A1 | EXTRACORPOREAL DEVICE AND MATRIX FOR REMOVING FIBRINOLYTIC PROTEINS FROM BIOLOGICAL FLUIDS, METHODS AND USES THEREOF | PLAS-FREE LTD (IL) | 2021-01-07 | — | — | US | claimed |
| EP-3746151-A1 | EXTRACORPOREAL DEVICE AND MATRIX FOR REMOVING FIBRINOLYTIC PROTEINS FROM BIOLOGICAL FLUIDS, METHODS AND USES THEREOF | PLAS-FREE LTD. (IL) | 2020-12-09 | — | — | EP | claimed |
| WO-2001098282-A1 | BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD (JP) | 2001-12-27 | — | — | WO | claimed |
| US-20010051348-A1 | Novel ligands and methods for preparing same | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2001-12-13 | — | — | US | claimed |
| US-6287538-B1 | CONTRAST AGENT | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-09-11 | — | — | US | claimed |
| WO-2001054731-A2 | LIGAND CONJUGATES AND METHODS FOR PREPARING SAME | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2001-08-02 | — | — | WO | claimed |
| WO-2001030749-B1 | NOVEL COMPOUNDS | NEW PHARMA RES SWEDEN AB (SE) | 2001-06-07 | — | — | WO | claimed |
| WO-2001023887-A1 | 2-AMINOPYRIDINE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-04-05 | — | — | WO | claimed |
| US-5859214-A | DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production | SCHERING AKTIENGESELLSHAFT (DE) | 1999-01-12 | — | — | US | claimed |
| US-5843399-A | DTPA monoamides for MRI | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-12-01 | — | — | US | claimed |
| EP-0450742-B1 | DTPA-Monoamids, pharmaceutical compositions containing them, their use and process for their preparation | SCHERING AG (DE) | 1994-07-06 | — | — | EP | claimed |
| US-5159109-A | Concurrent crystallization and steam distillation | AMOCO CORPORATION (US) | 1992-10-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213090-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | CD74, IL2, ICOS | LMNA 4857/4885PLG 4258/4885PLAT 4214/4885 |
| US-20220194931-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | CD74, IL2, ICOS | LMNA 4857/4885PLG 4258/4885PLAT 4214/4885 |
| US-20210001023-A1 | EXTRACORPOREAL DEVICE AND MATRIX FOR REMOVING FIBRINOLYTIC PROTEINS FROM BIOLOGICAL FLUIDS, METHODS AND USES THEREOF | PLG, FGB, PLAU | LMNA 1323/4885PLG 1/4885PLAT 5/4885 |
| US-20010051348-A1 | Novel ligands and methods for preparing same | ADGRF1, ADGRE5, TACR2 | LMNA 3462/4885PLG 1008/4885PLAT 1574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.